Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 4:13:1186378.
doi: 10.3389/fonc.2023.1186378. eCollection 2023.

Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis

Affiliations

Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis

Zhehan Chen et al. Front Oncol. .

Abstract

Objectives: Although guidelines recommend extended cholecystectomy for T2 gallbladder cancer (GBC), the optimal hepatectomy strategy remains controversial. The study aims to compare the prognosis of T2 GBC patients who underwent wedge resection (WR) versus segment IVb and V resection (SR) of the liver.

Methods: A specific search of online databases was performed from May 2001 to February 2023. The postoperative efficacy outcomes were synthesized and meta-analyses were conducted.

Results: A total of 9 studies involving 2,086 (SR = 627, WR = 1,459) patients were included in the study. The primary outcomes included disease-free survival (DFS) and overall survival (OS). For DFS, the 1-year DFS was statistically higher in patients undergoing SR than WR [risk ratio (RR) = 1.07, 95% confidence interval (CI) = 1.02-1.13, P = 0.007]. The 3-year DFS (P = 0.95), 5-year DFS (P = 0.77), and hazard ratio (HR) of DFS (P = 0.72) were similar between the two groups. However, the 3-year OS was significantly lower in patients who underwent SR than WR [RR = 0.90, 95% CI = 0.82-0.99, P = 0.03]. Moreover, SR had a higher hazard HR of OS [HR = 1.33, 95% CI = 1.01-1.75, P = 0.04]. No significant difference was found in 1-year (P = 0.32) and 5-year (P = 0.9) OS. For secondary outcomes, patients who received SR tended to develop postoperative complications (POC) [RR = 1.90, 95% CI = 1.00-3.60, P = 0.05]. In addition, no significant differences in intrahepatic recurrence (P = 0.12) were observed.

Conclusions: In conclusion, SR can improve the prognosis of T2 GBC patients in DFS. In contrast to WR, the high HR and complications associated with SR cannot be neglected. Therefore, surgeons should evaluate the condition of the patients and take their surgical skills into account when selecting SR.

Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier, CRD42022362974.

Keywords: gallbladder cancer; meta-analysis; prognosis; segment IVb/V resection; wedge resection.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
A flow diagram of the inclusion criteria of studies eligible for meta-analysis.
Figure 2
Figure 2
Result of the meta-analysis of OS between SR and WR, (A) 1-year OS. (B) 3-year OS. (C) 5-year OS. (D) HR of OS. SR, segment IVb and V resection of liver; WR, wedge resection of liver; OS, overall survival; HR, hazard ratio.
Figure 3
Figure 3
Result of the meta-analysis of DFS between SR and WR, (A) 1-year DFS. (B)3-year DFS. (C) 5-year DFS. (D) HR of DFS. SR, segment IVb and V resection of liver; WR, wedge resection of liver; DFS, disease-free survival; HR, hazard ratio.
Figure 4
Figure 4
Results of the meta-analysis between SR and WR. (A) POC. (B) IR. SR: segment IVb and V resection of liver; WR, wedge resection of liver; POC, postoperative complications; IR, intrahepatic recurrence.

Similar articles

Cited by

References

    1. Miller KD, Siegel RL, Lin C, Mariotto B, Kramer LJ, Rowland JH, et al. . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin (2016) 66:271–89. doi: 10.3322/caac.21349 - DOI - PubMed
    1. Nagakawa T, Kayahara M, Ikeda S, Futakawa S, Kakita A, Kawarada H, et al. . Biliary tract cancer treatment: results from the biliary tract cancer statistics registry in Japan. J Hepatobiliary Pancreat Surg (2002) 9:569–75. doi: 10.1007/s005340200076 - DOI - PubMed
    1. Buettner S, Margonis GA, Kim Y, Gani F, Ethun CG, Poultsides GA, et al. . Changing odds of survival over time among patients undergoing surgical resection of gallbladder carcinoma. Ann Surg Oncol (2016) 23:4401–9. doi: 10.1245/s10434-016-5470-2 - DOI - PMC - PubMed
    1. Chen M, Li S, Topatana W, Lv X, Cao J, Hu J, et al. . Development and validation of a nomogram for predicting survival in gallbladder cancer patients with recurrence after surgery. Front Oncol (2020) 10:537789. doi: 10.3389/fonc.2020.537789 - DOI - PMC - PubMed
    1. Horiguchi A, Miyakawa S, Ishihara S, Miyazaki M, Ohtsuka M, Shimizu H, et al. . Gallbladder bed resection or hepatectomy of segments 4a and 5 for pT2 gallbladder carcinoma: analysis of Japanese registration cases by the study group for biliary surgery of the Japanese society of hepato-Biliary-Pancreatic surgery. J Hepatobiliary Pancreat Sci (2013) 20:518–24. doi: 10.1007/s00534-012-0584-9 - DOI - PubMed

Publication types